A detailed history of Galvin, Gaustad & Stein, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Galvin, Gaustad & Stein, LLC holds 4,433 shares of MRK stock, worth $486,610. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,433
Previous 4,467 0.76%
Holding current value
$486,610
Previous $589,000 6.96%
% of portfolio
0.05%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

SELL
$123.8 - $132.96 $4,209 - $4,520
-34 Reduced 0.76%
4,433 $548,000
Q1 2024

Apr 15, 2024

SELL
$113.24 - $131.95 $16,306 - $19,000
-144 Reduced 3.12%
4,467 $589,000
Q4 2023

Jan 11, 2024

SELL
$100.18 - $109.02 $15,427 - $16,789
-154 Reduced 3.23%
4,611 $502,000
Q3 2023

Oct 18, 2023

SELL
$102.95 - $114.33 $20,692 - $22,980
-201 Reduced 4.05%
4,765 $490,000
Q2 2023

Jul 24, 2023

SELL
$108.61 - $118.38 $11,838 - $12,903
-109 Reduced 2.15%
4,966 $573,000
Q1 2023

Apr 17, 2023

BUY
$102.94 - $114.86 $13,176 - $14,702
128 Added 2.59%
5,075 $539,000
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $9,181 - $11,771
-105 Reduced 2.08%
4,947 $548,000
Q3 2022

Oct 26, 2022

BUY
$84.53 - $94.96 $2,535 - $2,848
30 Added 0.6%
5,052 $435,000
Q2 2022

Jul 22, 2022

SELL
$83.49 - $94.64 $15,779 - $17,886
-189 Reduced 3.63%
5,022 $458,000
Q1 2022

Apr 27, 2022

SELL
$73.51 - $82.4 $74,318 - $83,306
-1,011 Reduced 16.25%
5,211 $428,000
Q4 2021

Jan 31, 2022

SELL
$72.28 - $90.54 $44,741 - $56,044
-619 Reduced 9.05%
6,222 $477,000
Q3 2021

Oct 29, 2021

SELL
$71.68 - $78.83 $13.3 Million - $14.6 Million
-184,884 Reduced 96.43%
6,841 $514,000
Q2 2021

Jul 29, 2021

BUY
$70.31 - $77.77 $590,744 - $653,423
8,402 Added 4.58%
191,725 $14.9 Million
Q1 2021

Apr 19, 2021

BUY
$68.86 - $81.11 $1.86 Million - $2.2 Million
27,081 Added 17.33%
183,323 $14.1 Million
Q4 2020

Feb 04, 2021

BUY
$71.77 - $79.65 $11.2 Million - $12.4 Million
156,242 New
156,242 $12.8 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $278B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Galvin, Gaustad & Stein, LLC Portfolio

Follow Galvin, Gaustad & Stein, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Galvin, Gaustad & Stein, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Galvin, Gaustad & Stein, LLC with notifications on news.